- Design
- Nationwide population-based matched case-control study
- Population
- 624,713 singleton first births in Sweden, 2006-2023
- Primary outcome
- Preterm birth and spontaneous preterm birth
- Effect
- Preterm birth adjusted OR 0.95 (95% CI 0.91 to 0.99); very preterm 0.85 (0.75 to 0.97)
A nationwide Swedish matched case-control study examined 624,713 singleton first births to women aged 16 to 35 between 2006 and 2023; 14.8% of the mothers had received quadrivalent HPV vaccine before pregnancy.
After adjustment, vaccination was associated with lower odds of every adverse outcome studied. The significant ones were preterm birth (adjusted OR 0.95, 95% CI 0.91 to 0.99), very preterm birth at 28 to 31 weeks (0.85), spontaneous preterm birth (0.95) and severely small-for-gestational-age infants (0.92). The associations were stronger in women vaccinated younger.
A plausible link exists: HPV-related cervical disease and its treatment, such as excisional procedures, are known to raise preterm birth risk. But women who are vaccinated may differ in ways that adjustment does not fully capture. The practical point is reassurance, not a new indication: the vaccine is not associated with harm in later pregnancy, and the case for vaccinating early is strengthened.
- HPV vaccination before pregnancy was not associated with any adverse pregnancy outcome in over 600,000 births.
- The association with fewer preterm births was small and stronger with vaccination at younger ages.
- Use this to reassure parents and young women who ask whether vaccination affects later pregnancy.
- The study used the quadrivalent vaccine; whether other HPV vaccines show the same pattern was not examined.
Why it matters
Pregnancy safety is a frequent question from parents weighing HPV vaccination for their daughters.
Don't overread it
This is observational; it shows an association with fewer preterm births, not that the vaccine prevents them.
The statistics, in plain English
An odds ratio of 0.95 means about 5% lower odds, a small difference that only shows up as significant because the study is very large. The upper limit of 0.99 sits close to 1, so the true effect could be close to nothing. Residual confounding, unmeasured differences between vaccinated and unvaccinated women, could explain an effect this size.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for top clinical updates, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free